Current:Home > ContactEverything to Know About Xeomin, the Trendy Botox Alternative -GrowthProspect
Everything to Know About Xeomin, the Trendy Botox Alternative
View
Date:2025-04-17 11:15:27
When it comes to remaining ageless, celebrities are giving this trendy treatment a shot.
Xeomin, Botox's newer, cooler cousin, is quickly rising as the favorite muscle relaxer and wrinkle-reducer among Hollywood's biggest stars like Gwyneth Paltrow, Joe Jonas, Christina Aguilera, Teyana Taylor and Christie Brinkley. (Although, it's worth noting it could also be their go-to treatment because they're paid spokespersons for the injectable brand).
Additionally, many celebrities have praised Xeomin, which received FDA approval in 2010, for reducing their fine lines, while still allowing them to maintain a natural appearance instead of giving them the dreaded frozen face that Botox is often associated with.
And even though it's not permanent, this cosmetic procedure is more than just skin deep.
So before you decide to follow in Hollywood's footsteps, we asked double board-certified facial plastic surgeon Dr. Heather Lee to break down everything you need to know about Xeomin.
What is Xeomin?
Xeomin is the brand name of a neuromodulator—which is a very fancy word to describe muscle-relaxing injections of botulinum toxin—and it contains the same active ingredient of botulinum toxin type A or incobotulinumtoxinA as Botox and Dysport, according to Dr. Lee.
However, there's one main difference that sets Xeomin apart. "Unlike the others," Dr. Lee—who practices at The Quatela Center For Plastic Surgery—points out, "it does not have any associated accessory proteins, meaning that it only has botulinum toxin type A."
For this reason, the treatment has earned the nickname "naked Botox." But what exactly does that mean? Since there aren't any accessory proteins, the immune system isn't as affected. Plus, Dr. Lee said "there is less of a chance of developing antibodies to Xeomin" over time. However, the New York-based facial plastic surgeon noted that doesn't mean it's any less effective because it's missing an ingredient the other injectables have.
What are the benefits of Xeomin vs. Botox?
Both treatments, according to Dr. Lee, "work similarly to reduce lines and wrinkles by preventing muscle contraction."
And like Botox, Xeomin is FDA-approved for medical and aesthetic purposes. According to the American Academy of Facial Esthetics, doctors can use it both on-label and off-label for the glabellar lines—or, as it's commonly referred to, the "11s" between the frown lines and eyebrows—crow's feet and forehead wrinkles, in addition to medical conditions such as cervical dystonia, blepharospasm and upper limb spasticity.
One added benefit of using Xeomin, Dr. Lee shares, is that some studies have shown it "delivers a quicker onset of action." Think: Short treatment time, a faster recovery and noticeable results within two weeks.
And as far as how long Xeomin typically lasts, well, it's similar to others in that you can enjoy its benefits for three to four months, the facial plastic surgeon revealed. The only exception is Botox alternative Daxxify, in which the company claims that its injectable lasts six to nine months.
What are potential side effects of Xeomin?
No matter what injectable you choose, know that there are potential risks. With Xeomin, in particular, some possible side effects include swallowing, speaking or breathing difficulties, per the brand's website. Additionally, there is a chance the toxin may spread away from the injection site, with the brand noting you could experience blurred vision, loss of bladder control and muscle weakness all over the body.
Dr. Lee echoed similar sentiments, adding that other risks include "redness, swelling, pain, possible headache with injections in the forehead and drooping eyes or brows if injected incorrectly."
So, what's the takeaway?
Now that you know Xeomin offers many similarities to Botox and other alternatives, especially when it comes to wrinkle-reducing, efficacy and longevity, you can work closely with your practitioner to find the best treatment for your needs and desired results.
Sign up for E! Insider! Unlock exclusive content, custom alerts & more!veryGood! (11647)
Related
- Meta releases AI model to enhance Metaverse experience
- Democrats Embrace Price on Carbon While Clinton Steers Clear of Carbon Tax
- Who is Walt Nauta — and why was the Trump aide also indicted in the documents case?
- WHO renames monkeypox as mpox, citing racist stigma
- Average rate on 30
- Arts Week: How Art Can Heal The Brain
- A riding student is shot by her Olympian trainer. Will he be found not guilty by reason of insanity?
- Thanks to the 'tripledemic,' it can be hard to find kids' fever-reducing medicines
- Opinion: Gianni Infantino, FIFA sell souls and 2034 World Cup for Saudi Arabia's billions
- Sir Karl Jenkins Reacts to Coronation Conspiracy Suggesting He's Meghan Markle in Disguise
Ranking
- DoorDash steps up driver ID checks after traffic safety complaints
- Rihanna and A$AP Rocky's Baby Boy's Name Revealed
- 15 Canadian Kids Sue Their Government for Failing to Address Climate Change
- Dear Life Kit: How do I get out of my pandemic rut? Michelle Obama weighs in
- Highlights from Trump’s interview with Time magazine
- Is lecanemab the Alzheimer's drug that will finally make a difference?
- 24-Hour Sephora Deal: 50% Off a Bio Ionic Iron That Curls or Straightens Hair in Less Than 10 Minutes
- Russian state media says U.S. citizen has been detained on drug charges
Recommendation
Man can't find second winning lottery ticket, sues over $394 million jackpot, lawsuit says
Rihanna and A$AP Rocky's Baby Boy's Name Revealed
Brittney Griner allegedly harassed at Dallas airport by social media figure and provocateur, WNBA says
Sofia Richie Proves She's Still in Bridal Mode With Her Head-Turning White Look
Spooky or not? Some Choa Chu Kang residents say community garden resembles cemetery
Letters offer a rare look at the thoughts of The Dexter Killer: It's what it is and I'm what I am.
Twitter will no longer enforce its COVID misinformation policy
Today’s Climate: September 1, 2010